The Forxiga complex ‘Xigduo’ is approved, having high competitiveness in the market

As the complex of the first domestic SGLT-2(Sodium-Glucose Transport Proteins) inhibitor, ‘Forxiga(dapagliflozin),’ is about to be launched, the industry has paid attention to it.

According to the Ministiry of Food and Drug Safety on the 8^th, the AstraZeneca’s SGLT-2 inhibitor complex ‘Xigduo 10/500mg and 5/500mg’ were approved.

Xigduo, a complex combined Forxiga and metformin, is the first S...